Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

SIG reports modest rise in profit, announces new CEO

(Sharecast News) - SIG reported a modest rise in first-half operating profit on Tuesday, and confirmed its full-year outlook despite subdued demand across its European markets. The London-listed building materials supplier also named Pim Vervaat as its next chief executive, with a planned transition to chair in 2027.

Group revenue for the six months ended 30 June came in at £1.31bn, broadly flat on a like-for-like basis, while underlying operating profit rose to approximately £15m from £12m a year earlier.

The company said ongoing productivity initiatives were helping to offset weak demand and pricing pressures, particularly in Europe where construction activity remains at a low point in the cycle.

Like-for-like sales in the UK rose 5%, led by an 8% increase in the Interiors segment and a 5% gain in Roofing.

However, European operations saw a 1% decline, with sales down 7% in France Interiors and 4% in France Roofing.

Volumes were up 2% across the group, but a 1% net reduction in pricing offset modest inflation, leading to flat overall growth.

Net debt at the end of June stood at £525m, up from £497m in December, including leases.

Liquidity remained robust at £171m, supported by £81m in cash and an undrawn £90m revolving credit facility.

The group recorded a free cash outflow of about £10m during the period, with working capital initiatives mitigating much of the usual seasonal drag.

Its board maintained full-year guidance, stating it expected to deliver underlying operating profit in line with market expectations.

However, it noted that demand remained weak in the second quarter and expressed caution over the likelihood of any meaningful recovery in the near term.

"The board believes the group remains very well positioned to benefit from the market recovery when it occurs," SIG said.

Separately, SIG announced the appointment of Pim Vervaat as chief executive officer and chair designate.

Vervaat would assume the chief executive role on 1 October, succeeding Gavin Slark, who had stepped down and would remain on garden leave until the end of the year.

Vervaat previously served as CEO of Constantia Flexibles and led RPC Group as both CFO and CEO.

He is currently the senior independent director of Luceco plc.

Commenting on the appointment, chair Andrew Allner said: "The board is delighted to announce that Pim has agreed to join SIG as its CEO and non-executive chair designate.

"He has significant experience of operating in decentralised European businesses and a strong track record of delivering shareholder value."

Vervaat was expected to transition into the role of non-executive chair after approximately 18 months, when Allner steps down following a full term.

In the interim, CFO Ian Ashton would oversee daily operations.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.